Literature DB >> 22379057

Acute bovine viral diarrhea associated with extensive mucosal lesions, high morbidity, and mortality in a commercial feedlot.

Bill E Hessman1, David B Sjeklocha, Robert W Fulton, Julia F Ridpath, Bill J Johnson, Diana R McElroy.   

Abstract

In 2008, a northwest Texas feedlot underwent an outbreak of Bovine viral diarrhea virus (BVDV) causing high morbidity and mortality involving 2 lots of calves (lots A and B). Severe mucosal surface lesions were observed grossly in the oral cavity, larynx, and esophagus. Mucosal lesions varied from small (1-3 mm) infrequent mucosal ulcerations to large (5 mm to 1 cm) and coalescing ulcerations. Necrotic debris was present in ulcerations of some mortalities with some having plaque-like debris, but other mortalities presented more proliferative lesions. A calf persistently infected with BVDV arrived with one lot and the isolated virus was genotyped as BVDV-1b. Identical BVDV-1b strains were isolated from 2 other mortalities. A BVDV-2a genotype was also isolated in this outbreak. This genotype was identical to all BVDV-2a strains isolated in both lots. Serum samples were collected from exposed and unexposed animals and tested for antibodies for multiple viral pathogens. Seropositivity ranged from zero percent for calicivirus to 100% positive to Pseudocowpox virusx. At the end of the feeding period, the morbidity and mortality for the 2 lots involved was 76.2% and 30.8%, respectively, for lot A, and 49.0% and 5.6%, respectively, for lot B. Differential diagnoses included vesicular stomatitis viruses, Bovine papular stomatitis virus, and Foot-and-mouth disease virus. Based on the present case, acute BVDV should be considered when mucosal lesions are observed grossly.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22379057     DOI: 10.1177/1040638711436244

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  7 in total

1.  Generation of calves persistently infected with HoBi-like pestivirus and comparison of methods for detection of these persistent infections.

Authors:  F V Bauermann; S M Falkenberg; B Vander Ley; N Decaro; B W Brodersen; A Harmon; B Hessman; E F Flores; J F Ridpath
Journal:  J Clin Microbiol       Date:  2014-08-13       Impact factor: 5.948

2.  Epidemiology of bovine viral diarrhoea among tropical small holder dairy units in Kerala, India.

Authors:  Vinodkumar Kulangara; Anumol Joseph; Nandu Thrithamarassery; Asok Sivasailam; Latheef Kalappurackal; Saranya Mattappillil; Radhika Syam; Saseendranath Mapranath
Journal:  Trop Anim Health Prod       Date:  2015-01-24       Impact factor: 1.559

3.  A bovine viral diarrhea virus type 1a strain in China: isolation, identification, and experimental infection in calves.

Authors:  Wei Wang; Xinchuan Shi; Qin Tong; Yongwang Wu; Ming Qi Xia; Ye Ji; Wenzhi Xue; Hua Wu
Journal:  Virol J       Date:  2014-01-20       Impact factor: 4.099

4.  Zoonotic parapoxviruses detected in symptomatic cattle in Bangladesh.

Authors:  Edith Lederman; Salah Uddin Khan; Stephen Luby; Hui Zhao; Zachary Braden; JinXin Gao; Kevin Karem; Inger Damon; Mary Reynolds; Yu Li
Journal:  BMC Res Notes       Date:  2014-11-19

5.  Host response to bovine viral diarrhea virus and interactions with infectious agents in the feedlot and breeding herd.

Authors:  Robert W Fulton
Journal:  Biologicals       Date:  2012-08-11       Impact factor: 1.856

6.  BVD-2 outbreak leads to high losses in cattle farms in Western Germany.

Authors:  Jörn Gethmann; Timo Homeier; Mark Holsteg; Horst Schirrmeier; Michael Saßerath; Bernd Hoffmann; Martin Beer; Franz J Conraths
Journal:  Heliyon       Date:  2015-09-21

7.  Quinolinecarboxamides Inhibit the Replication of the Bovine Viral Diarrhea Virus by Targeting a Hot Spot for the Inhibition of Pestivirus Replication in the RNA-Dependent RNA Polymerase.

Authors:  Simone Musiu; Yunierkis Perez Castillo; Alexandra Muigg; Gerhard Pürstinger; Pieter Leyssen; Mathy Froeyen; Johan Neyts; Jan Paeshuyse
Journal:  Molecules       Date:  2020-03-12       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.